Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential clinical utility of genetic and platelet function tests in patients on treatment with clopidogrel.

Journal of cardiovascular medicine (Hagerstown, Md.) - 1 Dec 2013

Cattaneo Marco

Abstract excerpt

Clopidogrel, a pro-drug whose active metabolite is an inhibitor of the platelet P2Y12 receptor, is used mostly for the prevention of cardiovascular events in patients with acute coronary syndromes undergoing percutaneous coronary interventions. However, clopidogrel is associated with great variability in antiplatelet response, mostly caused by variable efficacy of cytochrome P450 (CYP) isoforms, which convert...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Coronary Syndrome
Share to Clopidogrel
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Platelet Aggregation

Share to Platelet Aggregation Inhibitors

Share to Platelet Function Tests

Share to Ticlopidine

Source

Identifiers

PMID: 24378837
DOI: 10.2459/JCM.0b013e328364bd3a

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential clinical utility of genetic and platelet function tests in patients on treatment with clopidogrel.PMID 24378837Read ↗

Identifying responsiveness to oral P2Y12 receptor blockers: platelet function assays and genetic tests.Semantic proximity Read ↗

[Evaluating the biological efficacy of clopidogrel: genotype or phenotype?].Semantic proximity Read ↗

Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms.Semantic proximity Read ↗

Clopidogrel and genetic testing: is it necessary for everyone?Semantic proximity Read ↗

Pharmacogenetics of Antiplatelet Therapy.Semantic proximity Read ↗

Response variability to P2Y12 receptor inhibitors: expectations and reality.Semantic proximity Read ↗

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read ↗

The pharmacogenetics of antiplatelet agents: towards personalized therapy?Semantic proximity Read ↗

Role of CYP2C19 genotype testing in clinical use of clopidogrel: is it really useful?Semantic proximity Read ↗

Pharmacogenetics of clopidogrel.Semantic proximity Read ↗

Most Recent Evidence Behind Aggregometry and Genotyping Methods as Platelet Function Testing for Tailored Anti-Platelet Treatment Among PCI Patients.Semantic proximity Read ↗

The genetic basis of platelet responsiveness to clopidogrel. A critical review of the literature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.